Investment
Features
FeesSafety
Academy
More
Pluang+

DelphX launches private placement to raise C$56,000 for working capital and overhead.

Company Fundamentals
22 Sep 2026
Newsfile Corp
View Source
Neutral
DelphX launches private placement to raise C$56,000 for working capital and overhead.

DelphX Capital Markets has started a non-brokered private placement to sell up to 5.6 million units at C$0.01 each, aiming to raise up to C$56,000. Each unit includes one common share and a warrant to buy another share at C$0.06 within two years. The funds will support working capital and corporate expenses, with up to 10% allocated for investor relations. The offering requires TSX Venture Exchange approval and includes a hold period on the securities issued. DelphX focuses on innovative structured financial products combining fixed income and cryptocurrency solutions.

DelphX Capital Markets' private placement announcement comes with this snapshot of the Financials sector on Pluang. For readers following Financials, here is Pluang's market snapshot as of Sep 23, 2026 03:01 WIB: Out of 83 priced US Financials stocks, 49 rose and 34 fell. Morgan Stanley (MS) traded at USD 200.22 with a 1-day change of -2.87% and a typical hold time of 95 days, while Riot Platforms Inc (RIOT) was at USD 24.85, up 2.86%, with a hold time of 15 days. Allstate Corp (ALL) stood at USD 242.76, down 2.83%, with a hold time of 74 days.

More News

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...

Analyst Insights
Neutral
2 hours ago
Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...

Market News
Bullish
2 hours ago
Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...

Market News
Bearish
2 hours ago
Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Jefferies maintains a Hold rating on Capri Holdings due to uncertainty over a potential takeover. Despite a flat global luxury market, Capri's management expects growth in the second half of 2026, driven by new product launches, increased marketing, ...

Analyst Insights
Neutral
3 hours ago
Qantas to sell tickets for New York-Sydney nonstop flights launching in 2028, with longer London-Sydney route planned.

Qantas to sell tickets for New York-Sydney nonstop flights launching in 2028, with longer London-Sydney route planned.

Qantas Airways will begin selling tickets next August for its first nonstop flight between New York and Sydney, set to launch in 2028. The flight will take about 18 hours using new Airbus A350-1000 ULR jets designed for ultra-long-haul travel. Additi...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App